How KPV Affects ESR

ESR does not measure inflammation directly. It measures how fast red cells settle in a column of plasma, which is driven mostly by fibrinogen and other acute phase proteins that make cells aggregate. Those proteins accumulate over days and clear over weeks.

KPV's mechanism sits upstream of that, in the same place it sits for CRP: NF-kB nuclear exclusion (Land, 2012, PMID 22837805) and suppression of IL-1beta, IL-6 and TNF-alpha (Dalmasso et al., 2008, PMID 18061177). Fewer inflammatory cytokines means less hepatic acute phase protein synthesis, which eventually means a lower ESR.

The word doing the work in that sentence is eventually. No study has measured ESR on KPV in any species, so this is mechanistic inference rather than a finding.

No direct evidence exists. ESR has not been measured as an endpoint in any published KPV study.

What the kinetics predict: ESR lags CRP by 24 to 48 hours on the way up and falls considerably slower on the way down, because it depends on plasma proteins with long half lives rather than on a single fast-turnover marker. On a 4 to 8 week protocol, CRP will move first and ESR may not have moved meaningfully at all by the time you re-test.

Reference range is age and sex dependent, which people routinely forget. Miller's rule gives an upper limit of age divided by 2 in mm/hr for men, and age plus 10 divided by 2 for women (Miller et al., 1983, PMID 6402065). ESR also drifts up with age independently of disease, around 1.19 times per decade, and runs higher in women (Siemons et al., 2014, PMID 25373740).

Order it at baseline alongside hs-CRP, then treat it as the slow-moving companion rather than the primary readout. If you only get one inflammatory marker, make it hs-CRP.

Calculate the right reference limit for the person, not the generic lab range. A 45 year old man has a different ceiling than a 25 year old, and using a single range for both produces false reassurance in one direction and false alarm in the other.

Interpret discordance carefully: a raised ESR with a normal CRP suggests something slower moving, or a non-inflammatory cause of raised plasma proteins such as anaemia or a paraprotein. A raised CRP with a normal ESR usually means the process is recent, which for this population most often means a hard training session two days ago.

Re-test at week 8, not week 4. There is little point checking ESR earlier than that on a peptide protocol.

Do not judge a short peptide run on ESR. The marker is too slow and the window is too short. If ESR has not moved at eight weeks, that is as consistent with the marker's kinetics as it is with the peptide doing nothing.

Check the obvious confounders before reading anything into it: anaemia raises ESR mechanically, as does pregnancy, and both are independent of inflammation. In an enhanced athlete, a suppressed or elevated haematocrit changes the result without any inflammation changing at all.

If ESR and CRP disagree persistently, believe neither and go looking for the source. Neither marker localises anything. Faecal calprotectin is the only test in this area that says the inflammation is in the gut.

Further reading: Does KPV peptide actually calm inflammation in the gut?